Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure-a cautionary case series

Crit Care. 2020 Jul 17;24(1):444. doi: 10.1186/s13054-020-03158-0.

Andreas Stallmach¹, Andreas Kortgen², Falk Gonnert³, Sina M Coldewey^{2

4

5}, Philipp Reuken¹, Michael Bauer^{6

7}

¹ Department of Internal Medicine IV (Gastroenterology, Hepatology, and Infectious Diseases), Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany.
² Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany.
³ Department of Anesthesiology and Intensive Care Medicine, SRH Wald-Klinikum Gera, Straße des Friedens 122, 07548, Gera, Germany.
⁴ Septomics Research Center, Jena University Hospital, 07745, Jena, Germany.
⁵ Center for Sepsis Control and Care, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany.
⁶ Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany. Michael.Bauer@med.uni-jena.de.
⁷ Center for Sepsis Control and Care, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany. Michael.Bauer@med.uni-jena.de.

No abstract available

Publication types